Zebra Biologics, Inc. — Form D
Zebra Biologics, Inc. of CONCORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-09. The offering totals $450, of which $450 was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-10-09
- Form: D
- Accession: 0001588698-13-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $450
- Amount sold: $450
- Investors: 11
- Date of first sale: 2013-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-204282
Issuer
- Name: Zebra Biologics, Inc.
- CIK: 0001588698
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1041 OLD MARLBORO ROAD, CONCORD, MA, 01742
- Phone: 978-505-8719
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Phillip M Frost | Director | Miami, FL |
| Ronald M Lindsay | Director | Concord, MA |
| Ronald M Lindsay | Executive Officer | Concord, MA |
| Richard A Lerner | Director | La Jolla, CA |
| Feng A Gao | Director | Temple City, CA |
Other filings by this issuer (2)
More